Fox 19: UC doctor part of team developing new COVID-19 antibody test
Transplant surgeon discusses ‘good’ and ‘bad’ antibodies along with false positives
Steve Woodle, MD, William A. Altemeier Chair in Research Surgery at the UC College of Medicine, is part of a national team working on a new test that can determine the effectiveness of antibodies against COVID-19 and also does a better job of reducing false positives in detecting the novel coronavirus.
“There’s scientific evidence that is accumulating, indicating that some antibodies can be good for you and some antibodies may be bad for you,” Woodle, a UC Health transplant surgeon, told Fox 19. “This test looks at five different types of antibodies and picks out particular combinations that exist in people who get well and people who struggle with recovering from the virus.”
The new test developed by a team of researchers at UC, Emory University and Toronto’s University Health Network along with Thermo Fisher Scientific can reduce the number of false positives for COVID-19, possibly triggered because a patient has antibodies for a common cold.
“No other test has that built into it that’s currently available in the market, but this test brings that,” Woodle told viewers.
Related Stories
Pocket-sized population threat
May 18, 2026
The Financial Times took a deep dive into why populations around the world continue to be on the decline. The publication cited new University of Cincinnati research as part of the investigation that looks at the fall of fertility in the digital era.
UC finds integrating substance use disorder treatment into clinic-based internal medicine expands access to care
May 18, 2026
A University of Cincinnati primary care teaching clinic integrates substance use disorder treatment into resident training, expanding access to addiction care and boosting physician confidence.
Colorado silica dust trial could change the way industry does business
May 17, 2026
Betsy Malloy, Andrew Katsanis Professor of Law, at the University of Cincinnati, spoke with Bloomberg Law about how a Colorado trial could change the way the stone fabrication industry does business.